Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lisa M.
Lisa M. Calandro, San Ramon, CA US
Lisa M. Cechetto, Ancaster CA
| Patent application number | Description | Published |
|---|---|---|
| 20080274049 | Cytotoxicity mediation of cells evidencing surface expression of CD44 - This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention. | 11-06-2008 |
| 20090022722 | Cytotoxicity mediation of cells evidencing surface expression of CD59 - This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention. | 01-22-2009 |
| 20090074659 | Cancerous disease modifying antibodies - The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells. | 03-19-2009 |
Lisa M. Ellerby, Novato, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090111748 | FIBROBLAST GROWTH FACTOR-2 PROMOTES NEUROGENESIS AND NEUROPROTECTION AND PROLONGS SURVIVAL IN HUNTINGTON'S DISEASE - This invention pertains to the discovery that fibroblast growth factor 2 (FGF2) stimulates neurogenesis, induces migration of newborn cells into the striatum and cortex, is neuroprotective, and significantly extends the lifespan mammals suffering from neurodegenerative conditions (e.g., Huntington's disease, Parkinson's disease, etc.). In certain embodiments this invention provides a method of promoting neurogenesis, neuroprotection and/or survival in a mammal having a neurodegenerative disease by upregulating expression or availability of endogenous fibroblast growth factor 2 (FGF2) in said mammal; and/or administering FGF2 or an FGF2 mutein to the mammal in an amount sufficient to promote neurogenesis, neuroprotection and/or survival of the mammal. | 04-30-2009 |
| 20110230527 | CASPASE INHIBITORS AND USES THEREOF - This invention provides novel caspase inhibitors useful for prophylaxis or treatment of a number of pathologies, including, for example, Huntington's disease. In certain embodiments the inhibitors include inhibitors of casepase-3 and/or casepase-6. | 09-22-2011 |
Lisa M. Erdmier, Winnetka, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080262955 | Apparatus to Facilitate Multi-Dimensional Representation of Financial Data - Trading information for securities is received and processed. This processing permits the determination of a close price for a current trading period, a close price for a previous trading period, a last trading price for the current trading period, a plurality of trading prices and corresponding trading volumes during the current trading period, and a plurality of trading prices and corresponding trading volumes during the previous trading period. This processed information is then output as a chart. By one approach, a relative minority of these items of processed information are additionally highlighted with a unique visual symbol. | 10-23-2008 |
Lisa M. Harlan-Williams, Lenexa, KS US
| Patent application number | Description | Published |
|---|---|---|
| 20090170842 | BRCA1-BASED BREAST OR OVARIAN CANCER PREVENTION AGENTS AND METHODS OF USE - A pharmaceutical composition for use in treating, inhibiting, and/or preventing breast and/or ovarian cancer can include: a molecule having a structure of one of Compounds 1-38, pharmaceutically acceptable salt thereof, or analog thereof, and a pharmaceutically acceptable carrier containing the compound. The pharmaceutically acceptable carrier can be configured for oral, systemic, transdermal, intranasal, suppository, parenteral, intramuscular, intravenous, or subcutaneous administration. The compound can be present in the composition in a therapeutically effective amount for treating, inhibiting, and/or preventing breast and/or ovarian cancer. Also, the compound can be present in a therapeutically effective amount for enhancing production of BRCA1. | 07-02-2009 |
| 20120259005 | BRCA1-Based Breast or Ovarian Cancer Prevention Agents and Methods of Use - A pharmaceutical composition for use in treating, inhibiting, and/or preventing breast and/or ovarian cancer can include: a molecule having a structure of one of Compounds 1-38, pharmaceutically acceptable salt thereof, or analog thereof; and a pharmaceutically acceptable carrier containing the compound. The pharmaceutically acceptable carrier can be configured for oral, systemic, transdermal, intranasal, suppository, parenteral, intramuscular, intravenous, or subcutaneous administration. The compound can be present in the composition in a therapeutically effective amount for treating, inhibiting, and/or preventing breast and/or ovarian cancer. Also, the compound can be present in a therapeutically effective amount for enhancing production of BRCA1. | 10-11-2012 |
Lisa M. Johnson, Marshall, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100099185 | METHOD OF MAKING BIOLOGICALLY ACTIVE ALPHA-BETA PEPTIDES - Described is a method of fabricating biologically active, unnatural polypeptides. The method includes the steps of selecting a biologically active polypeptide or biologically active fragment thereof having an amino acid sequence comprising α-amino acid residues, and fabricating a synthetic polypeptide that has an amino acid sequence that corresponds to the sequence of the biologically active polypeptide, but wherein about 14% to about 50% of the α-amino acid residues found in the biologically active polypeptide or fragment of step (a) are replaced with β-amino acid residues, and the α-amino acid residues are distributed in a repeating pattern. | 04-22-2010 |
Lisa M. Lugo-Paxton, Brainerd, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110265733 | Dog Boot - A dog boot is fabricated using a breathable substrate, preferably of durable material such as heavy nylon. Onto the substrate, various friction pads, wear pads, tensioning straps, and strategically located cushions are attached. Specially configured slits ensure that a wide range of leg sizes relative to paw sizes may be accommodated, while easing application of the boot and eliminating any risk of bunching. | 11-03-2011 |
Lisa M. Mcgurty, Livermore, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080245004 | AUTOMATIC TAKE-UP DEVICE AND IN-LINE COUPLER - A tension connection for a building includes a first elongated tension member having proximal and distal ends, the first elongated tension member being anchored at its distal end, a second elongated tension member having proximal and distal ends, the second elongated tension member being anchored at its distal end, and the proximal ends of the first and second elongated tension members being disposed in close proximity and connected by a coupler, having a surrounding sleeve, the coupler being formed with a connection end and a take-up end, and a central bore wherein at least a portion of the central bore is formed as a substantially cylindrical inner surface and wherein at least a portion of the cylindrical inner surface is formed with a thread, the coupler also being formed with a first rotational member, having a distal end and a proximal end, the rotational member being received in the central bore of the surrounding sleeve and operatively connected to the surrounding sleeve, the first rotational member having a cylindrical outer surface formed with a thread that mates with the thread of the cylindrical inner surface of the surrounding sleeve and is connected to the surrounding sleeve only by the mating attachment of the thread on the cylindrical outer surface with the thread of the surrounding sleeve, such that the rotational member can rotate in relation to the surrounding sleeve, and a torsion spring connects the first rotational member and the surrounding sleeve, the torsion spring biasing the first rotational member and the surrounding sleeve in opposite rotational directions such that the first rotational member can be drawn into the surrounding sleeve. | 10-09-2008 |
Lisa M. Miller Jenkins, Germantown, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20130096092 | THIOETHER PRODRUG COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS - Disclosed are inhibitors of retroviral growth of formula (I), that are useful in treatment of retroviral infections such as HIV. Also disclosed are a composition comprising a pharmaceutically acceptable carrier and at least one compound or salt of the invention, a method for inactivating a virus, a method for dissociating a metal ion from a zinc finger-containing protein, and a method for inhibiting the transmission of a virus. | 04-18-2013 |
Lisa M. Noni, Horseheads, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100043556 | SYSTEMS AND METHODS FOR MEASURING THE SPECIFIC MODULUS OF CELLULAR CERAMIC BODIES | 02-25-2010 |
Lisa M. Pisano-Ginter, Saint Augustine, FL US
Lisa M. Rimsza, Tueson, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20110159492 | Diffuse Large B-Cell Lymphoma Markers and Uses Therefore - The present invention provides methods and compositions for prognosing treatment outcome in DLBCL patients, diagnosing DLBCL and monitoring efficacy of DLBCL treatment. | 06-30-2011 |
Lisa M. Ryan-Hutton, Newburgh, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20090271740 | SYSTEM AND METHOD FOR MEASURING USER RESPONSE - A system and method for measuring user response to a stimulus, such as an advertisement, includes displaying the stimulus to the user, displaying a color bar to the user, and receiving a selection of a color from the color bar made by the user in response to the stimulus. The color bar may include a plurality of colors of various intensities and tones. Based on the color selected by the user, an emotional response metric to the stimulus may be determined. The emotional response metric may include, for example, the percentage of users selecting intense colors in response to the stimulus, the percentage of users selecting a particular tone of colors in response to the stimulus, and/or the percentage of users selecting a particular color in response to the stimulus. | 10-29-2009 |
Lisa M. Strassle, Magnolia, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080264099 | DOMESTIC GAS PRODUCT FROM AN LNG FACILITY - An LNG facility capable of producing a domestic gas product from an intermediate stream in the LNG facility. Withdrawing the domestic gas product from a location within the LNG facility can minimize operational disturbances typically caused by extracting a domestic gas product stream upstream of the liquefaction portion of the LNG facility. In addition, withdrawing the domestic gas product from this location can provide increased control of light contaminants (e.g., nitrogen) in open-loop refrigeration cycles and can ultimately result in incremental LNG and/or NGL production. | 10-30-2008 |
Lisa M. Strassle, Ponca City, OK US
| Patent application number | Description | Published |
|---|---|---|
| 20090301132 | OPTIMIZED HEAVIES REMOVAL SYSTEM IN AN LNG FACILITY - An LNG facility employing an optimized heavies removal system. The optimized heavies removal system can comprise at least one distillation column and at least two separate heat exchangers. The heat exchangers can be operable to heat a liquid stream withdrawn from a distillation column to thereby provide predominantly vapor and/or liquid streams that can be reintroduced into the column. | 12-10-2009 |
| 20100218551 | Method for Utilization of Lean Boil-Off Gas Stream as a Refrigerant Source - This invention relates to a system and method for liquefying natural gas. In another aspect, the invention concerns an improved liquefied natural gas facility employing a closed loop methane refrigeration cycle. In another aspect, the invention concerns the utilization of lean boil-off gas. | 09-02-2010 |
| 20100270208 | EFFICIENT METHOD FOR IMPROVED COKER GAS OIL QUALITY - An efficient delayed coking process improvement for producing heavy coker gas oil of sufficient quality to be used as hydrocracker feedstock. | 10-28-2010 |
Lisa M. Stroux, Oxford GB
| Patent application number | Description | Published |
|---|---|---|
| 20130023890 | PATELLA CLAMP AND DRILL GUIDE SURGICAL INSTRUMENT - An orthopaedic surgical instrument includes a patella drill guide having a first bracket, a second bracket coupled to the first bracket and moveable relative to the first bracket. The second bracket includes a drill plate having a plurality of guide holes defined therein. | 01-24-2013 |
Lisa M. Tyerman, Menlo Park, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100250946 | AD HOC DISTRIBUTION - Systems and methods for developing an application for a data processing device using a portal, such as a world wide web portal. In one exemplary method, an application signing certificate is generated using the portal, and the portal designates the data processing device using a unique device identifier. A unique application identifier for the application is created using the portal. An application provisioning file is created using the portal. The application provisioning profile comprises the application signing certificate, the unique application identifier, and the unique device identifier. | 09-30-2010 |
Lisa M. Valcich, Newburyport, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100328885 | Rotatable Cooling Module - A rotatable cooling module includes a cooling coil. An input line is coupled to the cooling coil via a coupler that allows the cooling coil to rotate independent of the input line. An output line is coupled to the cooling coil via a second coupler that allows the cooling coil to rotate independent of the output line. A coolant flows through the input line and the first coupler and passes through the cooling coil, which removes heat from an electronic assembly to which the cooling unit is attached. The coolant then flows through the second coupler and through the output line and returns to a heat exchanger, which cools the liquid before recirculating through the cooling unit. The couplers are disposed about a single axis which allows the cooling module to be rotated, and the couplers prevent damage from occurring to any of the elements of the cooling module. | 12-30-2010 |
Lisa M. Wice, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100268639 | Characterizing Creditworthiness Credit Score Migration - Data comprising a request to generate a migration score is received (for example, by a first computer system). The migration score characterizes a likelihood of a change in a level of creditworthiness of a consumer subsequent to generation of a current credit score. Thereafter, future credit score migration for the individual is estimated (for example, by the first computer system) using a predictive model trained using historical creditworthiness data derived from a plurality of individuals. The historical creditworthiness data includes, for each individual, a historical credit score and empirical performance data subsequent to a scoring date for the historical credit score. Thereafter, the estimated future credit score migration is associated (for example, by the first computer system) with a migration score. Provision of the migration score can then be initiated. Related apparatus, systems, techniques and articles are also described. | 10-21-2010 |
Lisa M. Wodicka, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120045769 | CELLULAR ASSAY EMPLOYING DETECTABLE PROTEIN - Provided herein are assays useful, for example, for determining the activity of a protein involved in a cellular process. In some embodiments, the activity of the protein is assessed using a nucleic acid tag, and in particular, by detecting the presence of a nucleic acid tag. Such assays can be used, for example, to study the effects of test compounds as modulators, e.g., inhibitors, agonists and antagonists, of protein activity. | 02-23-2012 |
Lisa M. Wolschlag, Aurora, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100150788 | Apparatus for Regenerating Catalyst - Disclosed is a catalyst distributor and process for spreading catalyst over a regenerator vessel. Nozzles disposed angular to a header of the distributor spread catalyst throughout a full cross section of the catalyst bed. | 06-17-2010 |
| 20100152020 | Process for Regenerating Catalyst - Disclosed is a catalyst distributor and process for spreading catalyst over a regenerator vessel. Nozzles disposed angular to a header of the distributor spread catalyst throughout a full cross section of the catalyst bed. | 06-17-2010 |
Lisa M. Wood Bradley, Cary, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100313140 | VISUAL OBJECT PRIORITIZATION - A system, method and program product for prioritizing visual objects for a configurable interface. A system is provided that includes a computer system having: a grouping system for defining a group of members and for assigning weights to members of the group; a behavior analysis system for collecting behaviors of the members of the group; and a prioritization system that prioritizes visual objects based on the collected behaviors and weights assigned to the members of the group. | 12-09-2010 |
| 20120143962 | Intelligent Email Management System - A method, apparatus, and computer program product for processing email messages. A processor unit generates an email processing profile for a user based on a number of registration activities by the user. Responsive to receiving an email message for the user, the processor unit processes the email message using the email processing profile. | 06-07-2012 |
Lisa M. Wright, Coffeyville, KS US
| Patent application number | Description | Published |
|---|---|---|
| 20090078159 | Pigment and Coating Composition Capable of Inhibiting Corrosion of Substrates - The present invention relates to a pigment and a coating composition comprising such a pigment, wherein it is contemplated that a coating composition containing such pigment is capable of inhibiting corrosion of a substrate to which it is applied. In one embodiment, the pigment comprises a filler having calcium borate, calcium molybdate, and calcium phosphate deposited on the surface of the filler. In an exemplary embodiment, the filler is calcium carbonate. | 03-26-2009 |
Lisa M. Youngclaus, Sparta, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100004970 | METHOD AND STRUCTURE FOR IMPLEMENTING B2B TRADING PARTNER BOARDING - A computerized method (and structure) of implementing a business-to-business (B2B) boarding process includes providing a set of questions related to the B2B boarding process to a new business to be boarded into an existing B2B system. | 01-07-2010 |